Document is current
Any future updates will be listed below
-
Authors
Eubler, Katja
Jeevanandan, Sree Priyanka
Caban, Karolina Magdalena
Stöckl, Jan Bernd
Braun, Malte Benjamin
Herrmann, Carola
Schneider, Michaela
Kreitmair, Nicole
Scholz, Lina
Mayr, Doris
Renkawitz, Jörg
Welter, Harald
Müller-Taubenberger, Annette
Fröhlich, Thomas
Mayerhofer, Artur https://orcid.org/0000-0002-9388-4639
-
Funding
Funding for this research was provided by:
Ludwig-Maximilians-Universität München
- License Information
-
More Information
Article History
Received: 29 September 2025
Accepted: 5 February 2026
First Online: 12 February 2026
Declarations
:
: In this study three human granulosa cell tumor (GCTs) RNA-samples were evaluated. These samples were described in a previous report [ ], all patients agreed to the scientific use of the tissue and the study was approved by the ethical committee of LMU (project 390-15). In addition, archival material of tissue microarrays (TMAs) consisting of 63 GCT samples was used for immunohistochemistry. This part of the study was approved by the ethical committee of LMU (projects 20-697 & 20-895). The use of human primary granulosa cells (hGCs) was approved by the ethical committee of LMU (project 20–697) and patients had agreed to the use of the cells. All experiments were performed in accordance with relevant guidelines and regulations.
: The authors declare no competing interests.
